J&J In Immunology: 'We Plan To Lead The Orals Market'

 
• By Jessica Merrill

Johnson & Johnson’s historical strength in immunology will form the foundation of a renewed push in the field, with novel candidates for indications such as psoriasis, arthritis and inflammatory bowel disease.    

pill box
J&J is developing two oral drugs for immunology indications • Source: Shutterstock

More from Immunological

More from Therapy Areas